BICLUSTER_ID : UPREG-56
PATHOGENS /3/ : listeria monocytogenes,bifidobacterium bifidum,yersinia enterocolitica
TARGETS /17/ : CCL20, PDE4B, TNFRSF1B, SERPINB2, GCH1, PIM1, TXNRD1, NFKB1, IL12B, GLRX, NP, IL6, IL1B, PTGS2, CASP1, HSPA1A, TNF
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPCSF3, CCL20, SERPINB2, MT2A, CXCL2, TXNRD1, NFKB1, CXCL1, LIF, NP, IL1A, CXCL5, IL6, IL1B, PTGS2, ZFP36
NETPATH IL 2 PATHWAY UPPDE4B, ISGF3G, TNFRSF1B, NMI, NR4A2, SOCS3, IFI44, FURIN, PIM1, FOSL2, CSF2, TXNRD1, IER3, CFLAR, IFIT1, SP100, LIF, TNFSF10, GADD45G, IL10, TRIM21, PRKX, RGS1, IL6, IL1B, DAXX, CASP1, UPP1, TNF, MX1
GERY CEBP TARGETSGADD45B, GLRX, CXCL1, EREG, JUNB, GADD45G, SERPINB2, CXCL5, ATF3, IFRD1, GCH1, PIM1, HSPA1A, DUSP1
NCI IL23PATHWAYSOCS3, IL6, IL12B, IL1B, CXCL1, TNF
NETPATH IL 4 PATHWAY DOWNUBE2L6, CCL20, GADD45B, IL7R, TNFSF10, GBP2, IL6, PTGS2, CXCL2, MX1, TNF
NETPATH IL 1 PATHWAYSQSTM1, NFKBIB, IL1RN, IL1B, CASP1, IL1A
NETPATH IL 4 PATHWAY UPNFKB1, MXD1, ELL2, MAF, ARID5B, IL10, SOCS3, IL6, IL1RN, RSAD2, INHBA, RIPK2, SLC11A2, CREM, UPP1
NCI IL1PATHWAYSQSTM1, NFKB1, IL1RN, IL1B, IL1A
NETPATH IL 3 PATHWAY UPNFIL3, SOCS3, CCL7, IL1B, TNF
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, JUNB, MAP3K8, SOCS3, ZFP36, PIM1, TNF, MX1
NCI NFKAPPABCANONICALPATHWAYNFKB1, TNFAIP3, RIPK2, TNF
NETPATH IL 5 PATHWAY UPPLSCR1, IL1A, MAPK6, IL1B, PMP22, FOSL2, UPP1, CASP4, IER3
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
NCI S1P S1P1 PATHWAY
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
CHUANG OXIDATIVE STRESS RESPONSE UP
KEGG GRAFT VERSUS HOST DISEASE
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
SESTO RESPONSE TO UV C0
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
NETPATH IL 7 PATHWAY UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI DISSOLUTION OF FIBRIN CLOT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
NCI HIF1 TFPATHWAY
XU AKT1 TARGETS 6HR
AMIT SERUM RESPONSE 60 MCF10A
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
LIU VAV3 PROSTATE CARCINOGENESIS UP
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BROWNE HCMV INFECTION 6HR UP
DAUER STAT3 TARGETS DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
MCLACHLAN DENTAL CARIES UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
CORUM ABIN2-NFKB1-MAP3K8 COMPLEX
LEE LIVER CANCER E2F1 UP
HELLER SILENCED BY METHYLATION UP
BOWIE RESPONSE TO TAMOXIFEN
GOZGIT ESR1 TARGETS DN
ZHOU INFLAMMATORY RESPONSE LPS UP
SMID BREAST CANCER LUMINAL B DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME CD28 CO STIMULATION
NCI IL12 2PATHWAY
TIAN TNF SIGNALING VIA NFKB
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
KEGG APOPTOSIS
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
CROONQUIST STROMAL STIMULATION UP
SIMBULAN UV RESPONSE NORMAL UP
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
BUDHU LIVER CANCER METASTASIS DN
KEGG JAK STAT SIGNALING PATHWAY
KEGG PRION DISEASES
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
ZERBINI RESPONSE TO SULINDAC UP
NCI PTP1BPATHWAY
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
SCHURINGA STAT5A TARGETS UP
MAHADEVAN RESPONSE TO MP470 UP
CORRE MULTIPLE MYELOMA UP
FERRARI RESPONSE TO FENRETINIDE UP
LE SKI TARGETS UP
CADWELL ATG16L1 TARGETS UP
BIOCARTA TID PATHWAY
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
ELVIDGE HIF1A AND HIF2A TARGETS DN
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
MOSERLE IFNA RESPONSE
WANG METHYLATED IN BREAST CANCER
RICKMAN HEAD AND NECK CANCER C
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
LIU TARGETS OF VMYB VS CMYB DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
STREICHER LSM1 TARGETS UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
BIOCARTA PML PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
LINDSTEDT DENDRITIC CELL MATURATION A
HOFMANN CELL LYMPHOMA DN
ELVIDGE HYPOXIA UP
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
NUYTTEN NIPP1 TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
MURATA VIRULENCE OF H PILORI
VART KSHV INFECTION ANGIOGENIC MARKERS UP
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
NEWMAN ERCC6 TARGETS UP
ISHIKAWA STING SIGNALING
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
BOQUEST STEM CELL CULTURED VS FRESH DN
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
NETPATH IL 2 PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
GRUETZMANN PANCREATIC CANCER UP
OKUMURA INFLAMMATORY RESPONSE LPS
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
KEGG TYPE I DIABETES MELLITUS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NETPATH EGFR1 PATHWAY DOWN
LEONARD HYPOXIA
AUJLA IL22 AND IL17A SIGNALING
LEE LIVER CANCER MYC TGFA UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WALLACE PROSTATE CANCER RACE UP
WIELAND UP BY HBV INFECTION
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
MAHADEVAN RESPONSE TO MP470 DN
RIGGINS TAMOXIFEN RESISTANCE DN
TSAI RESPONSE TO RADIATION THERAPY
UROSEVIC RESPONSE TO IMIQUIMOD
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
SOUCEK MYC TARGETS
BIOCARTA DC PATHWAY
BIOCARTA IL5 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
GOLDRATH ANTIGEN RESPONSE
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHU CMV 8 HR UP
BIOCARTA HSP27 PATHWAY
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
NCI IL27PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
XU HGF TARGETS INDUCED BY AKT1 6HR
AMIT EGF RESPONSE 240 HELA
ONDER CDH1 TARGETS 2 DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KEGG HEMATOPOIETIC CELL LINEAGE
LIAN LIPA TARGETS 3M
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
JISON SICKLE CELL DISEASE UP
NCI IL12 STAT4PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
YAMASHITA METHYLATED IN PROSTATE CANCER
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bclisteria monocytogenesbifidobacterium bifidumGeneSet Name
0.00001 0.00000 0.00007NETPATH_IL_1_PATHWAY_UP
0.00018 0.00068 0.07512NETPATH_IL_2_PATHWAY_UP
0.00510 0.00163 0.00008GERY_CEBP_TARGETS
0.00000 0.00100 0.00000NCI_IL23PATHWAY
0.00040 0.00001 0.00103NETPATH_IL_4_PATHWAY_DOWN
0.00206 0.00142 0.03028NETPATH_IL_1_PATHWAY
0.00000 0.00098 0.05727NETPATH_IL_4_PATHWAY_UP
0.01166 0.00886 0.00356NCI_IL1PATHWAY
0.00000 0.00553 0.01084NETPATH_IL_3_PATHWAY_UP
0.00000 0.00233 0.00007NETPATH_IL_6_PATHWAY_UP
0.04547 0.01014 0.01890NCI_NFKAPPABCANONICALPATHWAY
0.00159 0.00007 0.11144NETPATH_IL_5_PATHWAY_UP
0.00003 0.00014 0.00000BIOCARTA_IL10_PATHWAY
0.00000 0.00023 0.00214GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.11468 0.00965 0.07757NCI_S1P_S1P1_PATHWAY
0.03900 0.05829 0.06747BIOCARTA_STEM_PATHWAY
0.03120 0.08391 0.00950BIOCARTA_NFKB_PATHWAY
0.00009 0.00046 0.00474MAHAJAN_RESPONSE_TO_IL1A_UP
0.00000 0.01186 0.01898WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.11943 0.00900 0.00390CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.00055 0.00003 0.00101KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00237 0.00437 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00008 0.00776 0.01532BIOCARTA_IL1R_PATHWAY
0.00020 0.00001 0.13661KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00008 0.04054 0.00098RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00008 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.00171 0.00043 0.06739LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.08984 0.19899 0.10883ODONNELL_TFRC_TARGETS_UP
0.11863 0.00001 0.14665SESTO_RESPONSE_TO_UV_C0
0.00492 0.01417 0.01539IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00031 0.00068 0.00190AMIT_EGF_RESPONSE_40_HELA
0.00683 0.00007 0.00216BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00028 0.09197 0.01764NETPATH_IL_7_PATHWAY_UP
0.10630 0.00418 0.13478MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.00000 0.07330THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.02635 0.17554 0.17948NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.00004 0.00008 0.00139TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00000 0.00001 0.00013HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.11062 0.12454 0.06502KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00004 0.00004 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.19137 0.00889 0.18004NCI_HIF1_TFPATHWAY
0.00049 0.00065 0.00292XU_AKT1_TARGETS_6HR
0.00000 0.02234 0.15969AMIT_SERUM_RESPONSE_60_MCF10A
0.01191 0.00178 0.00919GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00263 0.00346 0.13458HAN_SATB1_TARGETS_DN
0.08100 0.01016 0.10808LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00001 0.00442SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.01254 0.00045 0.13421BROWNE_HCMV_INFECTION_6HR_UP
0.00220 0.00000 0.00000DAUER_STAT3_TARGETS_DN
0.00020 0.00000 0.00015GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00004 0.02592 0.00402AMIT_EGF_RESPONSE_120_HELA
0.01255 0.17317 0.00140BIOCARTA_RANKL_PATHWAY
0.04558 0.01850 0.10901DANG_REGULATED_BY_MYC_DN
0.00008 0.00000 0.00155MCLACHLAN_DENTAL_CARIES_UP
0.00857 0.01078 0.06171SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00001 0.00004 0.00133PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.16475 0.17672 0.12969CORUM_ABIN2-NFKB1-MAP3K8_COMPLEX
0.00219 0.02021 0.00724LEE_LIVER_CANCER_E2F1_UP
0.00028 0.07324 0.02743HELLER_SILENCED_BY_METHYLATION_UP
0.00077 0.00001 0.00013BOWIE_RESPONSE_TO_TAMOXIFEN
0.00135 0.03343 0.14873GOZGIT_ESR1_TARGETS_DN
0.00000 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00148 0.12803 0.13028SMID_BREAST_CANCER_LUMINAL_B_DN
0.00218 0.00011 0.00865ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00000 0.00000 0.02011VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00068 0.00001 0.02793BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.17138 0.03986 0.00260REACTOME_CD28_CO_STIMULATION
0.00140 0.04187 0.00033NCI_IL12_2PATHWAY
0.00000 0.00054 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00219 0.02242 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.19256 0.08467 0.11172KEGG_APOPTOSIS
0.00008 0.00031 0.05376HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00028 0.00002 0.01383CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00145 0.00001 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00013 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.00008 0.00167 0.08520CHANG_IMMORTALIZED_BY_HPV31_DN
0.01017 0.05925 0.01386CROONQUIST_STROMAL_STIMULATION_UP
0.04892 0.04183 0.02109SIMBULAN_UV_RESPONSE_NORMAL_UP
0.01394 0.10702 0.07904KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00041 0.00001 0.00007KIM_LRRC3B_TARGETS
0.19778 0.10505 0.10436DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00038 0.01805 0.00296HORIUCHI_WTAP_TARGETS_UP
0.15756 0.07255 0.00489ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.04786 0.00000 0.10663RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.01065 0.07558 0.11419CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.02068 0.03733 0.00290BUDHU_LIVER_CANCER_METASTASIS_DN
0.00015 0.17844 0.00000KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00471 0.00194 0.16095KEGG_PRION_DISEASES
0.02618 0.12603 0.05738TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.02491 0.01474 0.02695TSAI_DNAJB4_TARGETS_UP
0.00056 0.00000 0.02261DER_IFN_BETA_RESPONSE_UP
0.00299 0.00000 0.04303DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00313 0.12444 0.10056DIRMEIER_LMP1_RESPONSE_LATE_UP
0.01385 0.00438 0.00343SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00047 0.02298 0.00000BIOCARTA_CYTOKINE_PATHWAY
0.00003 0.00020 0.00006BASSO_CD40_SIGNALING_UP
0.00078 0.01298 0.06403TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.00045 0.05507NAGASHIMA_NRG1_SIGNALING_UP
0.00008 0.00507 0.02397MARZEC_IL2_SIGNALING_UP
0.12784 0.05033 0.11328ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01749 0.07255 0.05268NCI_PTP1BPATHWAY
0.00013 0.01616 0.07318CROMER_TUMORIGENESIS_UP
0.13847 0.15020 0.13001FRIDMAN_SENESCENCE_UP
0.03241 0.00791 0.10021WU_HBX_TARGETS_2_DN
0.03850 0.14595 0.11837SCHURINGA_STAT5A_TARGETS_UP
0.00000 0.00004 0.00318MAHADEVAN_RESPONSE_TO_MP470_UP
0.00296 0.10145 0.07602CORRE_MULTIPLE_MYELOMA_UP
0.00050 0.06128 0.05329FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.14439 0.10965 0.09185LE_SKI_TARGETS_UP
0.12327 0.05446 0.00063CADWELL_ATG16L1_TARGETS_UP
0.19083 0.07253 0.06186BIOCARTA_TID_PATHWAY
0.04758 0.05669 0.00015KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00000 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00005 0.05104 0.05362ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.01693 0.00055 0.00573KEGG_LEISHMANIA_INFECTION
0.19435 0.00371 0.13514ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00739 0.08533 0.02956WU_HBX_TARGETS_1_UP
0.00074 0.00000 0.07447CHEN_HOXA5_TARGETS_9HR_UP
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00030 0.00097 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00226 0.00060 0.00015CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.02118 0.07302 0.13415MURAKAMI_UV_RESPONSE_6HR_UP
0.01041 0.00000 0.07657BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00032 0.17968 0.02259WANG_METHYLATED_IN_BREAST_CANCER
0.00731 0.14781 0.05166RICKMAN_HEAD_AND_NECK_CANCER_C
0.00000 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.13527 0.00550 0.00436BIOCARTA_ASBCELL_PATHWAY
0.08106 0.05670 0.11294LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00805 0.00588 0.00006KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.02620 0.07385 0.13187STREICHER_LSM1_TARGETS_UP
0.00004 0.00001 0.09533HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00017 0.00142 0.00784ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00028 0.00423 0.01036AMIT_EGF_RESPONSE_120_MCF10A
0.00000 0.00001 0.01525OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.05386 0.00007 0.05087RUTELLA_RESPONSE_TO_HGF_UP
0.00119 0.01526 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00000 0.00887 0.00605PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.14639 0.00409 0.07855ELVIDGE_HIF1A_TARGETS_DN
0.02683 0.00624 0.04511BIOCARTA_PML_PATHWAY
0.00000 0.00069 0.00117TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00000 0.00001 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00000 0.00000 0.00005LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.11084 0.09034 0.13464HOFMANN_CELL_LYMPHOMA_DN
0.00036 0.00023 0.02232ELVIDGE_HYPOXIA_UP
0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.07282 0.03989 0.08284NCI_IL6_7PATHWAY
0.17905 0.00228 0.15636REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00741 0.00096 0.00294ROETH_TERT_TARGETS_UP
0.11392 0.00090 0.05475NUYTTEN_NIPP1_TARGETS_UP
0.00729 0.00030 0.02138TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00008 0.00736 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.08114 0.02078 0.02730MURATA_VIRULENCE_OF_H_PILORI
0.00016 0.01472 0.00397VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00032 0.00000 0.00779NUYTTEN_EZH2_TARGETS_UP
0.00013 0.01422 0.00215DUTTA_APOPTOSIS_VIA_NFKB
0.00000 0.00199 0.00294DIRMEIER_LMP1_RESPONSE_EARLY
0.00263 0.00068 0.00551DER_IFN_GAMMA_RESPONSE_UP
0.13189 0.00181 0.00179KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00003 0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00000 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00099 0.00011 0.01033ONDER_CDH1_TARGETS_3_DN
0.05249 0.00000 0.08197RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.08621 0.00001 0.13644NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.02049 0.00075 0.04912LIAN_LIPA_TARGETS_6M
0.00659 0.01127 0.04736NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00442 0.00186 0.01386WINTER_HYPOXIA_METAGENE
0.03715 0.09674 0.19779NEWMAN_ERCC6_TARGETS_UP
0.04998 0.02022 0.11417ISHIKAWA_STING_SIGNALING
0.00001 0.00001 0.06736GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00001 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00001 0.00007GAURNIER_PSMD4_TARGETS
0.00039 0.00001 0.00019FARMER_BREAST_CANCER_CLUSTER_1
0.00097 0.00061 0.00064GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.11465 0.03199 0.02093SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.14780 0.00123 0.11156NETPATH_TNF_ALPHA_PATHWAY_UP
0.02548 0.00005 0.07695MARKEY_RB1_CHRONIC_LOF_DN
0.02126 0.05101 0.17193BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00004 0.02216 0.05480GESERICK_TERT_TARGETS_DN
0.00097 0.02237 0.05582NOJIMA_SFRP2_TARGETS_DN
0.00000 0.00040 0.07807AMIT_SERUM_RESPONSE_120_MCF10A
0.01117 0.02477 0.02392LEE_LIVER_CANCER_MYC_E2F1_UP
0.00270 0.00002 0.00136SESTO_RESPONSE_TO_UV_C3
0.14409 0.07287 0.00063REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00000 0.00027 0.00426GEISS_RESPONSE_TO_DSRNA_UP
0.00007 0.00032 0.00145GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00226 0.07166 0.14936SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.01794 0.16339 0.09338CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.09647 0.09380 0.08923NETPATH_IL_2_PATHWAY
0.00000 0.00125 0.00015ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00149 0.01357 0.02965GRANDVAUX_IRF3_TARGETS_UP
0.00004 0.00000 0.03180ZHU_CMV_ALL_UP
0.15514 0.00031 0.12988GRUETZMANN_PANCREATIC_CANCER_UP
0.00041 0.00777 0.17661OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.14794 0.13098 0.06876NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00168 0.02848 0.02142LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00001 0.09324NAGASHIMA_EGF_SIGNALING_UP
0.04380 0.00200 0.02649AMIT_DELAYED_EARLY_GENES
0.02107 0.00007 0.00021KEGG_TYPE_I_DIABETES_MELLITUS
0.00000 0.01523 0.00467AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.02915 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00304 0.02668 0.00005NOJIMA_SFRP2_TARGETS_UP
0.00000 0.00001 0.01391OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00508 0.00015 0.08510SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.10486 0.05099 0.17140NETPATH_EGFR1_PATHWAY_DOWN
0.02593 0.00328 0.00822LEONARD_HYPOXIA
0.00824 0.00510 0.00419AUJLA_IL22_AND_IL17A_SIGNALING
0.14131 0.00938 0.13364LEE_LIVER_CANCER_MYC_TGFA_UP
0.00000 0.00001 0.00005TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.00031 0.00167WALLACE_PROSTATE_CANCER_RACE_UP
0.08414 0.00000 0.02002WIELAND_UP_BY_HBV_INFECTION
0.02619 0.00298 0.02725GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.09717 0.05928 0.05098ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.00009 0.01146 0.00016MAHADEVAN_RESPONSE_TO_MP470_DN
0.04319 0.03786 0.16665RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.02101 0.05481 0.00063TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00028 0.00008 0.00005UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00000 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00029 0.00000 0.05400HARRIS_HYPOXIA
0.00570 0.05671 0.08735NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00008 0.00000 0.00457FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.02878 0.04308 0.11437KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00008 0.09270 0.00012SOUCEK_MYC_TARGETS
0.04900 0.00005 0.00573BIOCARTA_DC_PATHWAY
0.01283 0.01405 0.05458BIOCARTA_IL5_PATHWAY
0.00004 0.00142 0.00389TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.06249 0.00386 0.10012IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00021 0.00177 0.01616ZHAN_MULTIPLE_MYELOMA_LB_DN
0.11422 0.00296 0.00055KEGG_AUTOIMMUNE_THYROID_DISEASE
0.17956 0.04561 0.00000GOLDRATH_ANTIGEN_RESPONSE
0.00353 0.00105 0.00315SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00000 0.00000 0.00118BILD_HRAS_ONCOGENIC_SIGNATURE
0.02597 0.00016 0.00011DAUER_STAT3_TARGETS_UP
0.00000 0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00389 0.00000 0.00081DER_IFN_ALPHA_RESPONSE_UP
0.06772 0.01410 0.13132MENSE_HYPOXIA_UP
0.01385 0.04745 0.03296DAZARD_UV_RESPONSE_CLUSTER_G2
0.00009 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00014 0.00000 0.00444MCLACHLAN_DENTAL_CARIES_DN
0.01133 0.00001 0.00011KEGG_ALLOGRAFT_REJECTION
0.00004 0.00799 0.01845AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.00001 0.10226BROWNE_HCMV_INFECTION_4HR_UP
0.02311 0.06782 0.05377WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000 0.00006ZHU_CMV_8_HR_UP
0.00586 0.12442 0.19777BIOCARTA_HSP27_PATHWAY
0.01398 0.07386 0.12900HELLER_SILENCED_BY_METHYLATION_DN
0.02071 0.05971 0.15084BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00004 0.00012 0.00002BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00000 0.00004 0.00019TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00318 0.04900 0.00000NCI_IL27PATHWAY
0.00026 0.00023 0.19319SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.02068 0.00954 0.04693XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00048 0.00272 0.07547AMIT_EGF_RESPONSE_240_HELA
0.00011 0.00554 0.09938ONDER_CDH1_TARGETS_2_DN
0.00006 0.00000 0.02116HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00360 0.12933 0.00313SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.00057 0.01434 0.03856KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.01896 0.00018 0.05374LIAN_LIPA_TARGETS_3M
0.00000 0.00007 0.08234UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00209 0.00000 0.00331JISON_SICKLE_CELL_DISEASE_UP
0.03431 0.03297 0.06861NCI_IL12_STAT4PATHWAY
0.00517 0.00850 0.10586XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00020 0.00595 0.05109DASU_IL6_SIGNALING_UP
0.00000 0.00001 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05022 0.00518 0.03751ZUCCHI_METASTASIS_DN
0.00004 0.01517 0.01831LU_IL4_SIGNALING
0.14838 0.09035 0.00294YAMASHITA_METHYLATED_IN_PROSTATE_CANCER